Evaluating Cerebrospinal Fluid Biomarkers in Alzheimer’s, Progressive Supranuclear Palsy Subjects, and Controls
Condition(s):Alzheimer Disease; Progressive Supranuclear PalsyLast Updated:October 24, 2014Completed
Hide Studies Not Open or Pending
Condition(s):Alzheimer Disease; Progressive Supranuclear PalsyLast Updated:October 24, 2014Completed
Condition(s):Diabetes Mellitus, Type 2Last Updated:January 17, 2013Completed
Condition(s):HDL CholesterolLast Updated:June 30, 2011Completed
Condition(s):Chronic Lymphocytic LeukemiaLast Updated:February 28, 2011Completed
Condition(s):Type 2 Diabetes Mellitus; Impaired Glucose ToleranceLast Updated:April 1, 2015Completed
Condition(s):Hepatitis CLast Updated:April 12, 2017Terminated
Condition(s):Non-alcoholic Fatty Liver DiseaseLast Updated:May 6, 2021Unknown status
Condition(s):Parkinson’s Disease; HIV InfectionsLast Updated:March 31, 2015Unknown status
Condition(s):DiabetesLast Updated:October 12, 2012Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.